rs148918638
Variant names:
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_001036.6(RYR3):c.11196G>A(p.Thr3732Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00114 in 1,613,924 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0015 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 4 hom. )
Consequence
RYR3
NM_001036.6 synonymous
NM_001036.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.293
Publications
2 publications found
Genes affected
RYR3 (HGNC:10485): (ryanodine receptor 3) The protein encoded by this gene is a ryanodine receptor, which functions to release calcium from intracellular storage for use in many cellular processes. For example, the encoded protein is involved in skeletal muscle contraction by releasing calcium from the sarcoplasmic reticulum followed by depolarization of T-tubules. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]
RYR3 Gene-Disease associations (from GenCC):
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen, G2P
- congenital myopathyInheritance: AR Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 15-33826703-G-A is Benign according to our data. Variant chr15-33826703-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 461838.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.293 with no splicing effect.
BS2
High Homozygotes in GnomAdExome4 at 4 AD,AR gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00151 AC: 230AN: 152158Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
230
AN:
152158
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00185 AC: 461AN: 249216 AF XY: 0.00203 show subpopulations
GnomAD2 exomes
AF:
AC:
461
AN:
249216
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00110 AC: 1607AN: 1461648Hom.: 4 Cov.: 31 AF XY: 0.00120 AC XY: 870AN XY: 727100 show subpopulations
GnomAD4 exome
AF:
AC:
1607
AN:
1461648
Hom.:
Cov.:
31
AF XY:
AC XY:
870
AN XY:
727100
show subpopulations
African (AFR)
AF:
AC:
5
AN:
33478
American (AMR)
AF:
AC:
27
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
AC:
60
AN:
26136
East Asian (EAS)
AF:
AC:
4
AN:
39698
South Asian (SAS)
AF:
AC:
138
AN:
86242
European-Finnish (FIN)
AF:
AC:
455
AN:
53402
Middle Eastern (MID)
AF:
AC:
14
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
833
AN:
1111832
Other (OTH)
AF:
AC:
71
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
84
168
252
336
420
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00150 AC: 229AN: 152276Hom.: 0 Cov.: 32 AF XY: 0.00185 AC XY: 138AN XY: 74460 show subpopulations
GnomAD4 genome
AF:
AC:
229
AN:
152276
Hom.:
Cov.:
32
AF XY:
AC XY:
138
AN XY:
74460
show subpopulations
African (AFR)
AF:
AC:
11
AN:
41544
American (AMR)
AF:
AC:
6
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
7
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5188
South Asian (SAS)
AF:
AC:
5
AN:
4820
European-Finnish (FIN)
AF:
AC:
99
AN:
10608
Middle Eastern (MID)
AF:
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
AC:
95
AN:
68026
Other (OTH)
AF:
AC:
3
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
11
22
34
45
56
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Sep 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
RYR3: BP4, BP7 -
Epileptic encephalopathy Benign:1
Apr 15, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.